UNDERWRITING AGREEMENTUnderwriting Agreement • February 3rd, 2017 • Interpace Diagnostics Group, Inc. • Surgical & medical instruments & apparatus • New York
This Underwriting Agreement (this “Agreement”) is dated as of February 3, 2017, between Interpace Diagnostics Group, Inc., a Delaware corporation (the “Company”), and the several underwriters (such underwriters, for whom Maxim Group LLC (“Maxim” or the “Representative”) is acting as representative, the “Underwriters” and each an “Underwriter”).
